137 related articles for article (PubMed ID: 34689150)
1. The IL-6R and Bmi-1 axis controls self-renewal and chemoresistance of head and neck cancer stem cells.
Herzog AE; Warner KA; Zhang Z; Bellile E; Bhagat MA; Castilho RM; Wolf GT; Polverini PJ; Pearson AT; Nör JE
Cell Death Dis; 2021 Oct; 12(11):988. PubMed ID: 34689150
[TBL] [Abstract][Full Text] [Related]
2. Targeting BMI1
Chen D; Wu M; Li Y; Chang I; Yuan Q; Ekimyan-Salvo M; Deng P; Yu B; Yu Y; Dong J; Szymanski JM; Ramadoss S; Li J; Wang CY
Cell Stem Cell; 2017 May; 20(5):621-634.e6. PubMed ID: 28285905
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional super-enhancers control cancer stemness and metastasis genes in squamous cell carcinoma.
Dong J; Li J; Li Y; Ma Z; Yu Y; Wang CY
Nat Commun; 2021 Jun; 12(1):3974. PubMed ID: 34172737
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic inhibition of Bmi-1 ablates chemoresistant cancer stem cells in adenoid cystic carcinoma.
Sahara S; Warner KA; Herzog AE; Zhang Z; Nör JE
Oral Oncol; 2023 Jul; 142():106437. PubMed ID: 37267716
[TBL] [Abstract][Full Text] [Related]
5. METTL3-mediated ALDH m
Chen Z; Chen J; Xu X; Li Q; Zhang C; Li S; Liu L; Cao C; Chen D; He Q
Oral Dis; 2024 Apr; 30(3):1061-1071. PubMed ID: 37249063
[TBL] [Abstract][Full Text] [Related]
6. Bmi-1: A master regulator of head and neck cancer stemness.
Herzog AE; Somayaji R; Nör JE
Front Oral Health; 2023; 4():1080255. PubMed ID: 36726797
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological inhibition of MYC to mitigate chemoresistance in preclinical models of squamous cell carcinoma.
Liu S; Qin Z; Mao Y; Wang N; Zhang W; Wang Y; Chen Y; Jia L; Peng X
Theranostics; 2024; 14(2):622-639. PubMed ID: 38169606
[No Abstract] [Full Text] [Related]
8. Humanized anti-DEspR IgG4
Gromisch CM; Tan GLA; Pasion KA; Moran AM; Gromisch MS; Grinstaff MW; Carr FJ; Herrera VLM; Ruiz-Opazo N
BMC Cancer; 2021 Apr; 21(1):407. PubMed ID: 33853558
[TBL] [Abstract][Full Text] [Related]
9. Endothelial-derived interleukin-6 induces cancer stem cell motility by generating a chemotactic gradient towards blood vessels.
Kim HS; Chen YC; Nör F; Warner KA; Andrews A; Wagner VP; Zhang Z; Zhang Z; Martins MD; Pearson AT; Yoon E; Nör JE
Oncotarget; 2017 Nov; 8(59):100339-100352. PubMed ID: 29245982
[TBL] [Abstract][Full Text] [Related]
10. Generation of a squamous cell carcinoma mouse model for lineage tracing of BMI1+ cancer stem cells.
Chen D; Zhang W; Jia L; Wang C; Wang CY
STAR Protoc; 2021 Jun; 2(2):100484. PubMed ID: 33982017
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor effect of inhibition of IL-6 signaling in mucoepidermoid carcinoma.
Mochizuki D; Adams A; Warner KA; Zhang Z; Pearson AT; Misawa K; McLean SA; Wolf GT; Nör JE
Oncotarget; 2015 Sep; 6(26):22822-35. PubMed ID: 26287605
[TBL] [Abstract][Full Text] [Related]
12. Discrimination of Cancer Stem Cell Markers ALDH1A1, BCL11B, BMI-1, and CD44 in Different Tissues of HNSCC Patients.
Sharaf K; Lechner A; Haider SP; Wiebringhaus R; Walz C; Kranz G; Canis M; Haubner F; Gires O; Baumeister P
Curr Oncol; 2021 Jul; 28(4):2763-2774. PubMed ID: 34287293
[TBL] [Abstract][Full Text] [Related]
13. Melatonin inhibits the stemness of head and neck squamous cell carcinoma by modulating HA synthesis via the FOSL1/HAS3 axis.
Luo X; Wang J; Chen Y; Zhou X; Shao Z; Liu K; Shang Z
J Pineal Res; 2024 Mar; 76(2):e12940. PubMed ID: 38402581
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.
Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH
J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019
[TBL] [Abstract][Full Text] [Related]
15. Adaptive c-Met-PLXDC2 Signaling Axis Mediates Cancer Stem Cell Plasticity to Confer Radioresistance-associated Aggressiveness in Head and Neck Cancer.
Lang L; Chen F; Li Y; Shay C; Yang F; Dan H; Chen ZG; Saba NF; Teng Y
Cancer Res Commun; 2023 Apr; 3(4):659-671. PubMed ID: 37089864
[TBL] [Abstract][Full Text] [Related]
16. The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy.
Hagege A; Ambrosetti D; Boyer J; Bozec A; Doyen J; Chamorey E; He X; Bourget I; Rousset J; Saada E; Rastoin O; Parola J; Luciano F; Cao Y; Pagès G; Dufies M
Theranostics; 2021; 11(19):9571-9586. PubMed ID: 34646387
[No Abstract] [Full Text] [Related]
17. Preventive cancer stem cell-based vaccination modulates tumor development in syngeneic colon adenocarcinoma murine model.
Eini L; Naseri M; Karimi-Busheri F; Bozorgmehr M; Ghods R; Madjd Z
J Cancer Res Clin Oncol; 2023 Jul; 149(7):4101-4116. PubMed ID: 36040667
[TBL] [Abstract][Full Text] [Related]
18. Complex interaction and heterogeneity among cancer stem cells in head and neck squamous cell carcinoma revealed by single-cell sequencing.
Xiao M; Zhang X; Zhang D; Deng S; Zheng A; Du F; Shen J; Yue L; Yi T; Xiao Z; Zhao Y
Front Immunol; 2022; 13():1050951. PubMed ID: 36451812
[TBL] [Abstract][Full Text] [Related]
19. FGFR signaling regulates resistance of head and neck cancer stem cells to cisplatin.
McDermott SC; Rodriguez-Ramirez C; McDermott SP; Wicha MS; Nör JE
Oncotarget; 2018 May; 9(38):25148-25165. PubMed ID: 29861860
[TBL] [Abstract][Full Text] [Related]
20. p53 Inhibits Bmi-1-driven Self-Renewal and Defines Salivary Gland Cancer Stemness.
Rodriguez-Ramirez C; Zhang Z; Warner KA; Herzog AE; Mantesso A; Zhang Z; Yoon E; Wang S; Wicha MS; Nör JE
Clin Cancer Res; 2022 Nov; 28(21):4757-4770. PubMed ID: 36048559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
